- Home
- HUBS vs BNTX Comparison
HUBS vs BNTX Comparison
Compare HUBS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUBS | BNTX |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 24.2B |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HUBS | BNTX |
|---|---|---|
| Price | $240.72 | $96.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 32 | 13 |
| Target Price | ★ $435.19 | $133.46 |
| AVG Volume (30 Days) | ★ 1.4M | 787.1K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 855.56 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $375,612,000.00 | N/A |
| Revenue This Year | $20.46 | N/A |
| Revenue Next Year | $16.01 | $3.37 |
| P/E Ratio | $256.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $187.45 | $79.81 |
| 52 Week High | $670.54 | $124.00 |
Technical Indicators
Market Signals| Indicator | HUBS | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.29 | 45.30 |
| Support Level | $209.40 | $91.74 |
| Resistance Level | $250.14 | $113.05 |
| Average True Range (ATR) | 12.02 | 3.65 |
| MACD | 3.02 | -0.38 |
| Stochastic Oscillator | 83.96 | 8.10 |
Price Performance
Historical ComparisonAbout HUBS HubSpot Inc.
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.